Simon J. Draper

South Parks Road
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 171 publications

Virus-like particle display of consensus α-neurotoxins does not enhance neutralising antibody responses against elapid venoms.

Virus-like particle display of consensus α-neurotoxins does not enhance neutralising antibody responses against elapid venoms.

Journal: Vaccine

Published: July 03, 2026

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Analysis of monoclonal antibodies against the malaria invasion complex protein RIPR reveals the structural basis for synergistic antibody protection.

Journal: Immunity

Published: January 27, 2026

Harnessing prophylactic vaccines for targeted cancer immunotherapy by phage-guided delivery of cognate antigens to tumors.

Harnessing prophylactic vaccines for targeted cancer immunotherapy by phage-guided delivery of cognate antigens to tumors.

Journal: Biomaterials

Published: December 22, 2025

Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.

Evaluating the potential of cross-species neutralization of anti-PfCyRPA and anti-PfRIPR Monoclonal Antibodies.

Journal: bioRxiv : the preprint server for biology

Published: December 03, 2025

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings.

Journal: Frontiers in immunology

Published: November 10, 2025

Addition of blood-stage antibody enhances anti-sporozoite antibody protection in a humanized mouse model of Plasmodium falciparum infection.

Addition of blood-stage antibody enhances anti-sporozoite antibody protection in a humanized mouse model of Plasmodium falciparum infection.

Journal: Cell reports

Published: September 19, 2025

A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies.

A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodies.

Journal: Npj viruses

Published: August 19, 2025

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection.

Journal: Nature communications

Published: June 20, 2025

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 18, 2025

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: June 18, 2025

Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope.

Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope.

Journal: EMBO reports

Published: April 01, 2025

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.

Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children.

Journal: The Lancet. Infectious diseases

Published: November 08, 2024

Showing 1-12 of 171

Last Updated: 09/26/2026